Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFrancesco De Cobelli
About this trial
The goal of this observational study is to collect data on efficacy and safety of microwave ablation (MWA) used to treat subjects with primary and secondary liver malignancies and renal malignancies. The main question it aims to evaluate the short, medium and long-term clinical course of patients treated with MWA.
Participants will not alter their normal clinical and therapeutic practice, due to the observational nature of the study, and all data regarding microwave treatments will be collected (including demographic data). follow their normal clinical and therapeutic path
Eligibility criteria
Qualifiers
> 18 years with primary or secondary liver tumors or small kidney tumors that are not candidates for surgery or cannot be radically resected by surgery alone
Primary liver cancer: up to three liver nodules ≤ 3 cm
Secondary hepatic tumours: up to nodules ≤ 3 cm provided that the objective is complete hepatic clearance Renal tumours: single or multiple (von Hippel Lindau syndrome), < 4 cm
Disqualifiers
pregnant women
non-manageable coagulopathies
Extended extrahepatic or extrarenal disease
for liver ablation: presence of bilio-digestive anastomosis
Trial design
Treatments tested in this trial
- Microwave ablation (MWA)
Treatment groups
500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Francesco De Cobelli
Lead sponsor
IRCCS San Raffaele
Sponsor institution
Source ClinicalTrials.gov